Takeda Looks to Offset Revenue Losses with Bolt-On Acquisition of URL Pharma

By Heather Cartwright

Pharma Deals Review: Vol 2012 Issue 4 (Table of Contents)

Published: 23 Apr-2012

DOI: 10.3833/pdr.v2012.i4.1729     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Takeda Pharmaceutical has agreed to buy the US speciality pharmaceutical company URL Pharma for US$800 M upfront plus contingent earn-out payments based on future performance...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details